BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22426675)

  • 1. Hormonal therapy for fertility and huge meningioma: a purely random association?
    Frassanito P; De Bonis P; Mattogno PP; Novello M; Anile C
    Acta Neurol Belg; 2012 Sep; 112(3):299-301. PubMed ID: 22426675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a symptomatic intracranial meningioma in a male-to-female transsexual after initiation of hormone therapy.
    Deipolyi AR; Han SJ; Parsa AT
    J Clin Neurosci; 2010 Oct; 17(10):1324-6. PubMed ID: 20594855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant.
    Piper JG; Follett KA; Fantin A
    Neurosurgery; 1994 Apr; 34(4):723-5; discussion 725. PubMed ID: 8008172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid growth and regression of intracranial meningiomas in lymphangioleiomyomatosis: case report.
    Pozzati E; Zucchelli M; Schiavina M; Contini P; Foschini MP
    Surg Neurol; 2007 Dec; 68(6):671-674. PubMed ID: 17586005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous hormone use and meningioma risk: what do we tell our patients?
    Claus EB; Black PM; Bondy ML; Calvocoressi L; Schildkraut JM; Wiemels JL; Wrensch M
    Cancer; 2007 Aug; 110(3):471-6. PubMed ID: 17580362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.
    Custer B; Longstreth WT; Phillips LE; Koepsell TD; Van Belle G
    BMC Cancer; 2006 Jun; 6():152. PubMed ID: 16759391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple meningiomas arising during long-term therapy with the progesterone agonist megestrol acetate. Case report.
    Gruber T; Dare AO; Balos LL; Lele S; Fenstermaker RA
    J Neurosurg; 2004 Feb; 100(2):328-31. PubMed ID: 15086241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual.
    Bergoglio MT; Gómez-Balaguer M; Almonacid Folch E; Hurtado Murillo F; Hernández-Mijares A
    Endocrinol Nutr; 2013 May; 60(5):264-7. PubMed ID: 23022362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple spinal meningiomas after tamoxifen therapy: a case report.
    Colazza GB; Di Gennaro G; Quarato PP; Colonnese C; Mascia A; Manfredi M
    Neurol Sci; 2003 Apr; 24(1):37-9. PubMed ID: 12754656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and Progesterone Therapy and Meningiomas.
    Hage M; Plesa O; Lemaire I; Raffin Sanson ML
    Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34935947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningioma in a woman receiving hormone therapy.
    Murata Y; Takeuchi S; Yoshida S; Miyoshi I
    Intern Med; 2003 Dec; 42(12):1267. PubMed ID: 14714974
    [No Abstract]   [Full Text] [Related]  

  • 12. Further data favouring hormonal dependency of cerebral meningiomas: evidence from a patient treated with cabergoline.
    Castelo-Branco C; Martinez MJ; Balasch J
    Gynecol Endocrinol; 2011 Feb; 27(2):134-7. PubMed ID: 20500108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial meningiomas in patients with uterine sarcoma treated with long-term megestrol acetate therapy.
    Gruber TJ; Fabiano AJ; Deeb G; Lele SB; Fenstermaker RA
    World Neurosurg; 2011 Nov; 76(5):477.e16-20. PubMed ID: 22152580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of a meningioma in a transsexual patient after estrogen-progestin therapy.
    Gazzeri R; Galarza M; Gazzeri G
    N Engl J Med; 2007 Dec; 357(23):2411-2. PubMed ID: 18057351
    [No Abstract]   [Full Text] [Related]  

  • 15. Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland.
    Korhonen K; Raitanen J; Isola J; Haapasalo H; Salminen T; Auvinen A
    Cancer Causes Control; 2010 Dec; 21(12):2149-56. PubMed ID: 20730482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningiomas in three male-to-female transgender subjects using oestrogens/progestogens and review of the literature.
    Ter Wengel PV; Martin E; Gooren L; Den Heijer M; Peerdeman SM
    Andrologia; 2016 Dec; 48(10):1130-1137. PubMed ID: 26888610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic Shrinkage with Reduced Vascularization of Large Meningiomas After Cessation of Progestin Treatment.
    Kalamarides M; Peyre M
    World Neurosurg; 2017 May; 101():814.e7-814.e10. PubMed ID: 28300711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormone replacement therapy and meningioma.
    Prescrire Int; 2010 Jun; 19(107):120. PubMed ID: 20738039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma.
    Harland TA; Freeman JL; Davern M; McCracken DJ; Celano EC; Lillehei K; Olson JJ; Ormond DR
    J Neurooncol; 2018 Jan; 136(2):327-333. PubMed ID: 29081037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple basaloma and meningioma following long-term arsenic therapy].
    Weiss J; Jänner M
    Hautarzt; 1980 Dec; 31(12):654-56. PubMed ID: 7204019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.